FDA Sued by Vape Industry Over New PMTA Deadline

The legal complaint was filed in the United States District Court for the Eastern District of Kentucky, in Lexington.

VTA is asking the court for “preliminary and permanent injunctive relief,” forcing the FDA to

• Propose and finalize a rule governing the submission of PMTAs
• Set a reasonable deadline for the filing of PMTAs, after the agency gives notice of a finalized rule, and allows a public comment period
• Not take enforcement action against legal vape products until after the new deadline for filing applications
• Not take enforcement action based on the recent court-imposed May 2020 deadline

“Absent prompt intervention by the Court, the overwhelming majority of the vaping industry, including over 160,000 jobs at small- and medium-sized businesses, will be destroyed,” the VTA complaint states.

There are more than three million vaping products registered with the FDA by domestic manufacturers. According to the VTA, “the arbitrary May 2020 PMTA deadline which FDA is currently enforcing is simply impossible to meet for thousands of small and mid-sized vapor businesses.”

“Grossly accelerating the deadlines and then repeatedly changing the already onerous requirements is unacceptable under any regulatory regime,” Abboud added, “but this is especially true for vapor products when FDA itself warns that ‘it is likely that there would be a mass market exit of ENDS products’ that 'could adversely affect the public health.’”

According to the lawsuit, there are not enough labs or even enough hours in the day for manufacturers to complete the scientific testing and analysis required by the FDA before the May 2020 deadline. That would be true even if only a small portion of vape manufacturers sought premarket approval.

How did we get here? The history of the PMTA deadline

The original deadline for submission of PMTAs, imposed as part of the FDA’s 2016 Deeming Rule, was Aug. 8, 2018. In July 2017, newly appointed FDA Commissioner Scott Gottlieb announced the deadline would be postponed until Aug. 8, 2022 to allow the FDA time to create and finalize what the agency said would be “foundational rules to make the product review process more efficient, predictable, and transparent for manufacturers.”

Then came the moral panic over youth vaping, and Gottlieb shifted from somewhat skeptical supporter of vaping as an alternative for adult smokers to an enthusiastic cheerleader for the widespread public fear and confusion over teen vaping that he called an epidemic. In March 2019 the agency announced it would move up the deadline to submit PMTAs for flavored products from 2022 to 2021.